A Case Report of Short-Term Metastasis After Surgery for Mammary Paget's Disease

Chao Wang1, Baiyi Yan1, Jing Wang1

  • 1Department of Breast Cancer Beijing Arion Cancer Center Beijing China.

Clinical Case Reports
|December 10, 2025
PubMed

Insights

Mammary Paget's disease (MPD) with ductal carcinoma in situ (DCIS) can spread quickly. Early imaging, surveillance, and managing anti-HER2 agent side effects are crucial for better patient outcomes.

Area of Science:

  • Oncology
  • Breast Cancer Research

Background:

  • Mammary Paget's disease (MPD) often co-occurs with ductal carcinoma in situ (DCIS).
  • Rapid metastasis is a significant concern in MPD with DCIS.
  • HER2-positive status is linked to aggressive disease progression.

Purpose of the Study:

  • To highlight the aggressive nature of HER2-positive MPD with DCIS.
  • To emphasize the need for prompt diagnostic and surveillance strategies.
  • To outline essential management principles for optimizing patient outcomes.

Main Methods:

  • Review of clinical presentations and pathological findings in MPD with DCIS.
  • Analysis of the impact of HER2 status on disease behavior.
  • Discussion of treatment modalities and supportive care strategies.

Main Results:

  • MPD with DCIS, particularly HER2-positive cases, demonstrates a propensity for rapid metastasis.
  • Early systemic imaging and vigilant surveillance are critical postoperatively.
  • Anti-HER2 therapies necessitate careful toxicity monitoring and management.

Conclusions:

  • Aggressive management is required for HER2-positive MPD with DCIS.
  • Personalized dose adjustments and multidisciplinary care are key to successful treatment.
  • Proactive management of treatment-related toxicities improves patient outcomes.

Related Concept Videos